![Theravance Biopharma, Inc. logo](/logos/TBPH.webp)
Theravance Biopharma, Inc.
NASDAQ:TBPH
Overview | Financials
Company Name | Theravance Biopharma, Inc. |
Symbol | TBPH |
Currency | USD |
Price | 8.01 |
Market Cap | 391,866,021 |
Dividend Yield | 0% |
52-week-range | 7.44 - 11.71 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Rick E. Winningham M.B.A. |
Website | https://www.theravance.com |
An error occurred while fetching data.
About Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK)
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD